Sandoz Group AG (SDZXF)
98.42
0.00 (0.00%)
USD |
OTCM |
Nov 16, 16:00
Sandoz Group Price : 98.42 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 0.000 |
| Nov 13, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 2416.00 |
| Nov 12, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 3.000 |
| Nov 11, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 0.000 |
| Nov 10, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 0.000 |
| Nov 09, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 0.000 |
| Nov 06, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 0.000 |
| Nov 05, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 13.00 |
| Nov 04, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 0.000 |
| Nov 03, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 0.000 |
| Nov 02, 2026 | 98.42 | 98.42 | 98.42 | 98.42 | 836.00 |
| Oct 30, 2026 | 100.50 | 100.50 | 100.50 | 100.50 | 348.00 |
| Oct 29, 2026 | 100.50 | 100.50 | 100.50 | 100.50 | 102.00 |
| Oct 28, 2026 | 95.35 | 95.35 | 95.35 | 95.35 | 100.00 |
| Oct 27, 2026 | 100.00 | 100.00 | 100.00 | 100.00 | 0.000 |
| Oct 26, 2026 | 100.00 | 100.00 | 100.00 | 100.00 | 180.00 |
| Oct 23, 2026 | 84.03 | 84.03 | 84.03 | 84.03 | 0.000 |
| Oct 22, 2026 | 84.03 | 84.03 | 84.03 | 84.03 | 1.000 |
| Oct 21, 2026 | 84.03 | 84.03 | 84.03 | 84.03 | 70.00 |
| Oct 20, 2026 | 84.03 | 84.03 | 84.03 | 84.03 | 96.00 |
| Oct 19, 2026 | 84.03 | 84.03 | 84.03 | 84.03 | 0.000 |
| Oct 16, 2026 | 84.03 | 84.03 | 84.03 | 84.03 | 0.000 |
| Oct 15, 2026 | 84.03 | 84.03 | 84.03 | 84.03 | 35.00 |
| Oct 14, 2026 | 84.03 | 84.03 | 84.03 | 84.03 | 0.000 |
| Oct 13, 2026 | 84.03 | 84.03 | 84.03 | 84.03 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 159.08 |
| Roche Holding AG | 60.95 |
| Addex Therapeutics Ltd. | 3.69 |
| Oculis Holding AG | 7.56 |
| Galderma Group AG | 45.48 |
Price Related Metrics
| PE Ratio | 66.68 |
| PS Ratio | 3.711 |
| PEG Ratio | 0.205 |
| Price to Free Cash Flow | 45.18 |
| Earnings Yield | 1.50% |
| Market Cap | 42.59B |
| PEGY Ratio | 0.2044 |
| Operating PE Ratio | 24.41 |
| Normalized PE Ratio | 66.68 |